Intrinsic Value of S&P & Nasdaq Contact Us

AMN Healthcare Services, Inc. AMN NYSE

NYSE • Healthcare • Medical - Care Facilities • US • USD

SharesGrow Score
39/100
1/7 Pass
SharesGrow Intrinsic Value
$91.08
+385%
Analyst Price Target
$22.88
+21.8%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

AMN Healthcare Services, Inc. (AMN) has a negative trailing P/E of -7.5, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 9.2 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -13.38%, forward earnings yield 10.83%.

Criteria proven by this page:

  • VALUE (90/100, Pass) — analyst target implies upside (+21.8%).
  • Forward P/E 9.2 — analysts expect a return to profitability with estimated EPS of $2.03 for FY2026.
  • Trailing Earnings Yield -13.38% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 10.83% as earnings recover.
  • Analyst consensus target $22.88 (+21.8% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 39/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score
39/100
SG Score
View full scorecard →
VALUE
90/100
Price-to-Earnings & upside
Proven by this page
~
FUTURE
58/100
Analyst consensus
→ Forecast
~
PAST
50/100
→ Income
HEALTH
17/100
Debt-to-Equity & liquidity
→ Health
MOAT
32/100
→ Income
GROWTH
15/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — AMN

Valuation Multiples
P/E (TTM)-7.5
Forward P/E9.2
PEG RatioN/A
Forward PEGN/A
P/B Ratio1.11
P/S Ratio0.26
EV/EBITDA14.7
Per Share Data
EPS (TTM)$-2.47
Forward EPS (Est.)$2.03
Book Value / Share$16.58
Revenue / Share$70.49
FCF / Share$6.04
Yields & Fair Value
Earnings Yield-13.38%
Forward Earnings Yield10.83%
Dividend Yield0.00%
SharesGrow IV$91.08 (+385%)
Analyst Target$22.88 (+21.8%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 17.4 0.61 4.10 0.97 -
2017 17.8 0.70 4.19 1.18 -
2018 18.9 2.38 4.20 1.26 -
2019 25.5 -1.39 3.95 1.31 -
2020 45.8 -1.18 3.95 1.35 -
2021 17.8 0.05 5.02 1.46 -
2022 10.3 0.23 4.39 0.87 -
2023 13.9 -0.30 3.53 0.77 -
2024 -6.2 0.04 1.29 0.31 -
2025 -6.3 0.18 0.95 0.22 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $2.15 $1.9B $105.84M 5.6%
2017 $2.68 $1.99B $132.56M 6.7%
2018 $2.91 $2.14B $141.74M 6.6%
2019 $2.40 $2.22B $113.99M 5.1%
2020 $1.48 $2.39B $70.67M 3%
2021 $6.81 $3.98B $327.39M 8.2%
2022 $9.90 $5.24B $444.05M 8.5%
2023 $5.36 $3.79B $210.68M 5.6%
2024 $-3.85 $2.98B $-146.98M -4.9%
2025 $-2.48 $2.73B $-95.7M -3.5%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $2.03 $1.59 – $2.26 $3.17B $3.15B – $3.18B 6
2027 $1.12 $1.00 – $1.28 $2.69B $2.68B – $2.7B 5
2028 $1.07 $1.06 – $1.09 $2.79B $2.79B – $2.79B 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message